基于开放状态的腹腔镜根治性子宫切除术与开腹根治性子宫切除术治疗早期宫颈癌的III期随机临床试验
该III期单中心开放标签随机试验计划纳入740例早期宫颈癌患者,按1:1随机分配至基于开放状态的腹腔镜根治性子宫切除术组或开腹根治性子宫切除术组,主要终点为4.5年无病生存率,旨在验证两种术式的等效性。
要点
- 早期宫颈癌标准治疗为根治性子宫切除术加盆腔淋巴结清扫。
- 近年文献认为腹腔镜手术治疗宫颈癌的结局劣于开腹手术。
- 本试验比较基于开放状态的腹腔镜手术与开腹手术的肿瘤和生存结局。
核心结论
- 这项前瞻性试验旨在按两阶段方案证明基于开放状态的腹腔镜宫颈癌手术与经腹根治性子宫切除术在早期宫颈癌患者中的等效性。
研究设计与样本
- 开放标签、两臂、随机、III期单中心试验,比较基于开放状态的腹腔镜根治性子宫切除术与开腹根治性子宫切除术。
- 计划共纳入740例受试者,按1:1比例随机分配至2个治疗组。
- 基线收集临床、实验室、超声和放射学数据,并在基线及术后1周、6周、3个月进行研究评估和操作。
- 术后3个月开始随访,前2年每3个月一次,之后每6个月一次直至第4.5年。
主要发现
- 主要目标为4.5年无病生存率。
- 次要目标包括治疗相关发病率、费用与成本效果、复发模式、生活质量、盆底功能和总生存期。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cervical cancer is the fourth most frequently diagnosed cancer and the fourth leading cause of cancer death in women, The standard treatment recommendation for women with early cervical cancer is radical hysterectomy with pelvic lymph node dissection, however, articles published in recent years have concluded that the treatment outcome of laparoscopic surgery for cervical cancer is inferior to that of open surgery. Thus, we choose a surgically new approach; the laparoscopic cervical cancer surgery in the open state is compared with the traditional open cervical cancer surgery, and we hope that patients can still have a good tumor outcome and survival outcome. This trial will investigate the effectiveness of laparoscopic cervical cancer surgery in the open-state treatment of early-stage cervical cancer. METHOD AND DESIGN: This will be an open-label, 2-armed, randomized, phase-III single-center trial of comparing laparoscopic radical hysterectomy based on open state with abdominal radical hysterectomy in patients with early-stage cervical cancer. A total of 740 participants will be randomly assigned into 2 treatment arms in a 1:1 ratio. Clinical, laboratory, ultrasound, and radiology data will be collected at baseline, and then at the study assessments and procedures performed at baseline and 1 week, 6 weeks, and 3 months, and follow-up visits begin at 3 months following surgery and continue every 3 months thereafter for the first 2 years and every 6 months until year 4.5. The primary aim is the rate of disease-free survival at 4.5 years. The secondary aims include treatment-related morbidity, costs and cost-effectiveness, patterns of recurrence, quality of life, pelvic floor function, and overall survival. CONCLUSIONS: This prospective trial aims to show the equivalence of the laparoscopic cervical cancer surgery in the open state versus the transabdominal radical hysterectomy approach for patients with early-stage cervical cancer following a 2-phase protocol. TRIAL REGISTRATION: ChiCTR2300075118. Registered on August 25, 2023.
引用
- Zhao X, Liu Y, Niu J, et al. A phase III randomized clinical trial comparing laparoscopic radical hysterectomy based on open state with abdominal radical hysterectomy in patients with early-stage cervical cancer. Trials. 2024. PMID: 38992720. doi:10.1186/s13063-024-08318-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。